30 June 2022

Business Update, Final Results and Financing Agreement

Shield Provides a Business Update, its Final Results for the Year Ended 31 December 2021 and announces a financing agreement of US$10 million

Shield Therapeutics plc today reports a business update covering recent developments, its audited final results for the year ended 31 December 2021 and details of a financing transaction of US$10 million through a shareholder loan from AOP Orphan International AG (‘AOP’).  Upon completion this transaction will extend the Company’s cash runway to approximately the end of calendar 2022.

For full details click here.

Back to News